Literature DB >> 10579914

Plasminogen-related growth factor and semaphorin receptors: a gene superfamily controlling invasive growth.

P M Comoglio1, L Tamagnone, C Boccaccio.   

Abstract

Plasminogen-related growth factors (PRGFs), also known as "scatter factors," trigger a unique biological program leading to "invasive growth." This is a result of the integration of apparently independent biological responses including cell proliferation, cell survival, cell motility, invasion of extracellular matrices, and induction of cell polarity. Under physiological conditions, the coordinated execution of the underlying genetic programs leads to the formation of tubular structures by epithelial organs (the so-called branching morphogenesis). PRGF receptors are tyrosine kinases, encoded by a family of oncogenes: MET and RON. They feature unique signal transduction properties as their cytoplasmic tails contain a two-tyrosine multifunctional docking site that binds multiple SH2-containing intracellular signal transducers. Invasive growth results from the concomitant activation of Ras (growth), phosphatidylinositol 3-kinase ("scattering"), and signal transducer and activator of transcription (cell polarity and morphogenesis). We recently identified a new human gene family, encoding large transmembrane proteins, sex/plexins, sharing homologies with Met. These molecules are receptors for semaphorins, involved in axon guidance and cell-cell repulsion, a process reminiscent of scattering and invasive growth. Deregulated activation of PRGF or semaphorin ligands or receptors, by mutation or overexpression, confers to cancer cells invasive and metastatic properties. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579914     DOI: 10.1006/excr.1999.4684

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

Review 1.  Semaphorins as signals for cell repulsion and invasion.

Authors:  Yoshio Goshima; Takaaki Ito; Yukio Sasaki; Fumio Nakamura
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

2.  Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B.

Authors:  Y Tomizawa; Y Sekido; M Kondo; B Gao; J Yokota; J Roche; H Drabkin; M I Lerman; A F Gazdar; J D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer.

Authors:  Doina Joseph; Shuk-Mei Ho; Viqar Syed
Journal:  Mol Cancer Ther       Date:  2010-02-02       Impact factor: 6.261

4.  Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair.

Authors:  Chang-Goo Huh; Valentina M Factor; Aránzazu Sánchez; Koichi Uchida; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

Review 5.  Semaphorins and their receptors in lung cancer.

Authors:  Vincent A Potiron; Joëlle Roche; Harry A Drabkin
Journal:  Cancer Lett       Date:  2008-07-14       Impact factor: 8.679

Review 6.  Ron-receptor tyrosine kinase in tumorigenesis and metastasis.

Authors:  Mike A Leonis; Megan N Thobe; Susan E Waltz
Journal:  Future Oncol       Date:  2007-08       Impact factor: 3.404

7.  Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility.

Authors:  Mihyun H Bae; Gregory B Bissonette; Wendy M Mars; George K Michalopoulos; Cristian L Achim; Didier A Depireux; Elizabeth M Powell
Journal:  Exp Neurol       Date:  2009-10-22       Impact factor: 5.330

8.  Upregulated expression of Ezrin and invasive phenotype in malignantly transformed esophageal epithelial cells.

Authors:  Zhong-Ying Shen; Li-Yan Xu; Ming-Hua Chen; En-Min Li; Jin-Tao Li; Xian-Ying Wu; Yi Zeng
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

9.  The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells.

Authors:  Hang-Ping Yao; Yong-Qing Zhou; Qi Ma; Sunny Guin; Snehal S Padhye; Rui-Wen Zhang; Ming-Hai Wang
Journal:  Mol Cancer       Date:  2011-07-12       Impact factor: 27.401

10.  Catalytically inactive human cathepsin D triggers fibroblast invasive growth.

Authors:  Valérie Laurent-Matha; Sharon Maruani-Herrmann; Christine Prébois; Mélanie Beaujouin; Murielle Glondu; Agnès Noël; Marie Luz Alvarez-Gonzalez; Sylvia Blacher; Peter Coopman; Stephen Baghdiguian; Christine Gilles; Jadranka Loncarek; Gilles Freiss; Françoise Vignon; Emmanuelle Liaudet-Coopman
Journal:  J Cell Biol       Date:  2005-01-24       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.